Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
By L. Malcovati, U. Germing, A. Kuendgen, M. D. Della Porta, C. Pascutto, R. Invernizzi, A. Giagounidis, B. Hildebrandt, P. Bernasconi, S. Knipp and 4 more. Journal of Clinical Oncology, 2007
1,034 citations recorded by the source corpus.
Subfields: Genetics, Hematology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/56c47480d6a809a241cae2033be8aa68c5552757
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Hematology
Citations in the corpus
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. (2013, methodology): “These variables were integrated into a WHO classification-based prognostic scoring system (WPSS), which is able to classify patients into 5 risk groups with different survivals and probabilities of leukemic evolution (supplemental Table 4).(98,99) This scoring system has been validated in different ”
- Revised international prognostic scoring system for myelodysplastic syndromes. (2012, methodology): “The changes from the cutpoints used in the IPSS-R compared with those from the IPSS include (1) separating marrow blasts 5% into 0%-2% and 2- 5%; and (2) providing differing depths of cytopenias; also, as patients with marrow blasts of 10%-20% had similar outcomes as those with 21%-30%; and (3) Tabl”